Your browser doesn't support javascript.
loading
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.
Nixon, Iain J; Ganly, Ian; Patel, Snehal G; Palmer, Frank L; Di Lorenzo, Monica M; Grewal, Ravinder K; Larson, Steven M; Tuttle, R Michael; Shaha, Ashok; Shah, Jatin P.
Affiliation
  • Nixon IJ; Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Thyroid ; 23(6): 683-94, 2013 Jun.
Article in En | MEDLINE | ID: mdl-23742290

Full text: 1 Database: MEDLINE Main subject: Thyroidectomy / Thyroid Neoplasms / Carcinoma / Radiopharmaceuticals / Iodine Radioisotopes Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Thyroid Year: 2013 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Thyroidectomy / Thyroid Neoplasms / Carcinoma / Radiopharmaceuticals / Iodine Radioisotopes Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Thyroid Year: 2013 Type: Article Affiliation country: United States